BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9699741)

  • 1. Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family.
    Borradori L; Trüeb RM; Jaunin F; Limat A; Favre B; Saurat JH
    J Invest Dermatol; 1998 Aug; 111(2):338-40. PubMed ID: 9699741
    [No Abstract]   [Full Text] [Related]  

  • 2. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin.
    Mahoney MG; Aho S; Uitto J; Stanley JR
    J Invest Dermatol; 1998 Aug; 111(2):308-13. PubMed ID: 9699735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies.
    Kazerounian S; Mahoney MG; Uitto J; Aho S
    J Invest Dermatol; 2000 Sep; 115(3):505-7. PubMed ID: 10951291
    [No Abstract]   [Full Text] [Related]  

  • 4. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex.
    Kiyokawa C; Ruhrberg C; Nie Z; Karashima T; Mori O; Nishikawa T; Green KJ; Anhalt GJ; DiColandrea T; Watt FM; Hashimoto T
    J Invest Dermatol; 1998 Dec; 111(6):1236-8. PubMed ID: 9856851
    [No Abstract]   [Full Text] [Related]  

  • 5. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients.
    Zhang B; Zheng R; Wang J; Bu D; Zhu X
    J Invest Dermatol; 2006 Apr; 126(4):832-40. PubMed ID: 16470171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
    Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
    Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin.
    Nagata Y; Karashima T; Watt FM; Salmhofer W; Kanzaki T; Hashimoto T
    J Invest Dermatol; 2001 Apr; 116(4):556-63. PubMed ID: 11286623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making sense of antigens and antibodies in pemphigus.
    Anhalt GJ
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):763-6. PubMed ID: 10321608
    [No Abstract]   [Full Text] [Related]  

  • 9. Envoplakin and periplakin are the paraneoplastic pemphigus antigens.
    Kiyokawa C
    Kurume Med J; 1999; 46(1):71-8. PubMed ID: 10319615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human autoantibodies against HD1/plectin in paraneoplastic pemphigus.
    Proby C; Fujii Y; Owaribe K; Nishikawa T; Amagai M
    J Invest Dermatol; 1999 Feb; 112(2):153-6. PubMed ID: 9989789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
    Li J; Bu DF; Huang YC; Zhu XJ
    Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human autoantibodies against desmoplakins in paraneoplastic pemphigus.
    Oursler JR; Labib RS; Ariss-Abdo L; Burke T; O'Keefe EJ; Anhalt GJ
    J Clin Invest; 1992 Jun; 89(6):1775-82. PubMed ID: 1601988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoblotting detection of gamma-catenin (plakoglobin) antibody in the serum of a patient with paraneoplastic pemphigus.
    Ishii M; Izumi J; Fujiwara H; Ito M; Hamada M
    Br J Dermatol; 2001 Feb; 144(2):377-9. PubMed ID: 11251577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of autoantibodies to periplakin and envoplakin in paraneoplastic pemphigus but not idiopathic pulmonary fibrosis using full-length recombinant proteins.
    Muro Y; Sugiura K; Shiraki A; Ishii N; Hashimoto T; Akiyama M
    Clin Chim Acta; 2014 Feb; 429():14-7. PubMed ID: 24275244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus.
    de Bruin A; Müller E; Wyder M; Anhalt GJ; Lemmens P; Suter MM
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):682-5. PubMed ID: 10321593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.
    Probst C; Schlumberger W; Stöcker W; Recke A; Schmidt E; Hashimoto T; Zhu XJ; Zillikens D; Komorowski L
    Clin Chim Acta; 2009 Dec; 410(1-2):13-8. PubMed ID: 19737550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.
    Verrini A; Cannata G; Cozzani E; Terracini M; Parodi A; Rebora A
    Acta Derm Venereol; 2002; 82(5):382-4. PubMed ID: 12430743
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera.
    Brandt O; Rafei D; Podstawa E; Niedermeier A; Jonkman MF; Terra JB; Hein R; Hertl M; Pas HH; Müller R
    J Invest Dermatol; 2012 Jun; 132(6):1738-41. PubMed ID: 22318391
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and immunopathological spectrum of paraneoplastic pemphigus.
    Zimmermann J; Bahmer F; Rose C; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2010 Aug; 8(8):598-606. PubMed ID: 20180886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.